Rapport Therapeutics RAPP
NASDAQ RAPP
$45.77 -1.88 (-3.95%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rapport Therapeutics (RAPP) Net Shares Issued and Repurchased (2024 - 2026)

Analysis

Rapport Therapeutics (RAPP) Net Shares Issued and Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Rapport Therapeutics 2.17 Bn 2.17 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.94 Mn
Dec 31, 2025 2.52 Mn
Mar 31, 2025 1.63 Mn
Dec 31, 2024 2.87 Mn